Transaction supports further development of SER-155, following recent promising clinical data, and other cultivated live biotherapeutics, for multiple medically vulnerable […]
ATLANTA, Sept. 30, 2024 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ:FA), a leading provider of employment background screening, identity and […]